XAF1 and glioblastoma: While there was caspase 3 activation in both WT and XAF1 silenced (XAF1-KD) U251 GBM xenografts, caspase 3 was more markedly (p < 0.05) activated in XAF1 silenced group compared to WT control group (Fig. 6d).